======= TRIM13 ======= == Gene Information == * **Official Symbol**: TRIM13 * **Official Name**: tripartite motif containing 13 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10206|10206]] * **UniProt**: [[https://www.uniprot.org/uniprot/O60858|O60858]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TRIM13&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TRIM13|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605661|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Endoplasmic reticulum (ER) membrane anchored E3 ligase involved in the retrotranslocation and turnover of membrane and secretory proteins from the ER through a set of processes named ER-associated degradation (ERAD). This process acts on misfolded proteins as well as in the regulated degradation of correctly folded proteins. Enhances ionizing radiation-induced p53/TP53 stability and apoptosis via ubiquitinating MDM2 and AKT1 and decreasing AKT1 kinase activity through MDM2 and AKT1 proteasomal degradation. Regulates ER stress-induced autophagy, and may act as a tumor suppressor (PubMed:22178386). Plays also a role in innate immune response by stimulating NF-kappa-B activity in the TLR2 signaling pathway. Ubiquitinates TRAF6 via the 'Lys-29'-linked polyubiquitination chain resulting in NF-kappa-B activation (PubMed:28087809). Participates as well in T-cell receptor- mediated NF-kappa-B activation (PubMed:25088585). In the presence of TNF, modulates the IKK complex by regulating IKBKG/NEMO ubiquitination leading to the repression of NF-kappa-B (PubMed:25152375). {ECO:0000269|PubMed:17314412, ECO:0000269|PubMed:21333377, ECO:0000269|PubMed:22178386, ECO:0000269|PubMed:25088585, ECO:0000269|PubMed:25152375, ECO:0000269|PubMed:28087809}. |zf-C3HC4| |zf-B box| |negative regulation of viral release from host cell| |endoplasmic reticulum mannose trimming| |perinuclear endoplasmic reticulum| |protein alpha-1,2-demannosylation| |protein demannosylation| |endoplasmic reticulum quality control compartment| |negative regulation of viral transcription| |protein deglycosylation| |regulation of viral release from host cell| |response to gamma radiation| |regulation of viral transcription| |protein autoubiquitination| |positive regulation of macroautophagy| |ubiquitin-dependent ERAD pathway| |negative regulation of viral life cycle| |ERAD pathway| |negative regulation of viral process| |positive regulation of autophagy| |regulation of viral life cycle| |response to ionizing radiation| |positive regulation of NF-kappaB transcription factor activity| |regulation of macroautophagy| |positive regulation of I-kappaB kinase/NF-kappaB signaling| |regulation of viral process| |negative regulation of multi-organism process| |regulation of symbiosis, encompassing mutualism through parasitism| |ubiquitin protein ligase activity| |regulation of I-kappaB kinase/NF-kappaB signaling| |ubiquitin-protein transferase activity| |response to endoplasmic reticulum stress| |positive regulation of DNA-binding transcription factor activity| |negative regulation of locomotion| |proteasome-mediated ubiquitin-dependent protein catabolic process| |regulation of autophagy| |proteasomal protein catabolic process| |positive regulation of cellular catabolic process| |glycoprotein metabolic process| |regulation of DNA-binding transcription factor activity| |positive regulation of catabolic process| |response to radiation| |ubiquitin-dependent protein catabolic process| |modification-dependent protein catabolic process| |modification-dependent macromolecule catabolic process| |proteolysis involved in cellular protein catabolic process| |cellular protein catabolic process| |protein catabolic process| |protein ubiquitination| |positive regulation of cell death| |innate immune response| |protein modification by small protein conjugation| |regulation of multi-organism process| |regulation of cellular catabolic process| |zinc ion binding| |cellular macromolecule catabolic process| |endoplasmic reticulum membrane| |defense response to other organism| |regulation of locomotion| |protein modification by small protein conjugation or removal| |regulation of catabolic process| |response to organonitrogen compound| |positive regulation of intracellular signal transduction| |carbohydrate derivative metabolic process| |macromolecule catabolic process| |organonitrogen compound catabolic process| |response to nitrogen compound| |response to abiotic stimulus| |proteolysis| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |defense response| |positive regulation of signal transduction| |regulation of cell death| |cellular response to stress| |organic substance catabolic process| |positive regulation of molecular function| |cellular catabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |immune response| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp306|Rapamycin 2μM R07 exp306]]|-2| |[[:results:exp336|Asunaprenir 3μM R07 exp336]]|-1.86| |[[:results:exp382|Palbociclib 1μM R07 exp382]]|-1.81| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 16884 * **Expression level (log2 read counts)**: 5.99 {{:chemogenomics:nalm6 dist.png?nolink |}}